1ttm

From Proteopedia
Revision as of 20:21, 12 November 2007 by OCA (talk | contribs) (New page: left|200px<br /> <applet load="1ttm" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ttm, resolution 1.95Å" /> '''Human carbonic anhy...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
File:1ttm.gif


1ttm, resolution 1.95Å

Drag the structure with the mouse to rotate

Human carbonic anhydrase II complexed with 667-coumate

OverviewOverview

CA (carbonic anhydrase) catalyses the reversible hydration of carbon, dioxide into bicarbonate, and at least 14 isoforms have been identified in, vertebrates. The role of CA type II in maintaining the fluid and pH, balance has made it an attractive drug target for the treatment of, glaucoma and cancer. 667-coumate is a potent inhibitor of the novel, oncology target steroid sulphatase and is currently in Phase 1 clinical, trials for hormone-dependent breast cancer. It also inhibits CA II in, vitro. In the present study, CA II was crystallized with 667-coumate and, the structure was determined by X-ray crystallography at 1.95 A (1 A=0.1, nm) resolution. The structure reported here is the first for an inhibitor, based on a coumarin ring and shows ligation of the sulphamate group to the, active-site zinc at 2.15 A through a nitrogen anion. The first two rings, of the coumarin moiety are bound within the hydrophobic binding site of CA, II. Important residues contributing to binding include Val-121, Phe-131, Val-135, Leu-141, Leu-198 and Pro-202. The third seven-membered ring is, more mobile and is located in the channel leading to the surface of the, enzyme. Pharmacokinetic studies show enhanced stability of 667-coumate in, vivo and this has been ascribed to binding of CA II in erythrocytes. This, result provides a structural basis for the stabilization and long, half-life of 667-coumate in blood compared with its rapid disappearance in, plasma, and suggests that reversible binding of inhibitors to CA may be a, general method of delivering this type of labile drug.

DiseaseDisease

Known disease associated with this structure: Osteopetrosis, autosomal recessive 3, with renal tubular acidosis OMIM:[611492]

About this StructureAbout this Structure

1TTM is a Single protein structure of sequence from Homo sapiens with ZN and 667 as ligands. Active as Carbonate dehydratase, with EC number 4.2.1.1 Full crystallographic information is available from OCA.

ReferenceReference

Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent., Lloyd MD, Pederick RL, Natesh R, Woo LW, Purohit A, Reed MJ, Acharya KR, Potter BV, Biochem J. 2005 Feb 1;385(Pt 3):715-20. PMID:15453828

Page seeded by OCA on Mon Nov 12 19:27:55 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA